Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer

Immunotherapy has recently become widely used in lung cancer. Many oncologists are focused on cytotoxic T lymphocyte antigen‐4 (CTLA‐4), programmed cell death ligand‐1 (PD‐L1) and programmed cell death‐1 (PD‐1). Immunotherapy targeting the PD‐1/PD‐L1 checkpoints has shown promising efficacy in non‐s...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yayi, Rivard, Christopher J., Rozeboom, Leslie, Yu, Hui, Ellison, Kim, Kowalewski, Ashley, Zhou, Caicun, Hirsch, Fred R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021038/
https://www.ncbi.nlm.nih.gov/pubmed/27297395
http://dx.doi.org/10.1111/cas.12986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021038/
https://www.ncbi.nlm.nih.gov/pubmed/27297395
http://dx.doi.org/10.1111/cas.12986

Ejemplares similares